News
Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...
Identified themes and highlights include scientific discovery and tools, current politics, and funding constraints.
Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian cancer.
We talk about news in cancer, updates on COVID's origin, and business news in biotech in this episode of Touching Base.
Bacteria like A. borkumensis are important for degrading oil pollution, so these findings are of significant interest.
Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique ...
Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...
Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...
To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...
The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...
Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly ...
From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results